¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"biological transport, active"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • active hyperemia
    ´Éµ¿ÃæÇ÷
  • active imagination
    Àû±Ø»ó»ó, Àû±Ø¸í»ó
  • active immunity
    ´Éµ¿¸é¿ª
  • active immunization
    ´Éµ¿¸é¿ªÈ­
  • active incorporative mode
    Àû±ØÇÔÀÔ¾ç½Ä
  • active marrow
    Ȱ¼º°ñ¼ö
  • active material
    Ȱ¼º¹°Áú, Ȱ¼ºÀç
  • active movement
    ´Éµ¿¿îµ¿
  • active negativism
    Àû±Ø°ÅºÎÁõ
  • active oxygen
    Ȱµ¿»ê¼Ò, Ȱ¼º»ê¼Ò
  • active phase
    Ȱ¼º±â
  • active placebo
    Ȱ¼º¼ÓÀÓ¾à
  • active prosthesis
    Ȱµ¿ÀÇÁö, ´Éµ¿ÀÇÁö
  • active shielding
    ´Éµ¿Â÷Æó
  • active shimming
    ´Éµ¿º¸Á¤
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • passive transport
    ¼öµ¿¿î¹Ý
  • supersonic transport
    ÃÊÀ½ÆÄ¼ö¼Û
  • transport
    ¿î¹Ý
  • transcapillary transport
    ¸ð¼¼°ü¿î¹Ý
  • transmembrane transport
    ¸·¿î¹Ý
  • active
    ´Éµ¿-, Àû±Ø-, Ȱ¼º-
  • active carbon
    Ȱ¼º½¡, Ȱ¼ºÅº
  • active electrode
    Ȱµ¿Àü±Ø
  • active exercise
    ´Éµ¿¿îµ¿
  • active hydrogen
    Ȱ¼º¼ö¼Ò
  • active hyperemia
    ´Éµ¿ÃæÇ÷
  • active imagination
    Àû±Ø»ó»ó, Àû±Ø¸í»ó
  • active immunity
    ´Éµ¿¸é¿ª
  • active immunization
    ´Éµ¿¸é¿ªÈ­
  • active marrow
    Ȱ¼º°ñ¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • active exercise
    ÀÚµ¿¿îµ¿(í»ÔÑê¡ÔÑ).
  • active exercise
    ÀÚµ¿¿îµ¿(í»ÔÑê¡ÔÑ).
  • active force generation test
    ±Ù·Â°Ë»ç
  • active glycine
    Ȱ¼º(üÀàõ)±Û¸®½Å.
  • active gradient shielding
    ´Éµ¿ °æ»ç Â÷Æó
  • active hydrogen
    Ȱ¼º¼ö¼Ò(¡­â©áÈ).
  • active imagination
    Àû±ØÀû »ó»ó
  • active immunity
    ´Éµ¿¸é¿ª(ÒöÔÑØóæ¹).
  • active immunization
    ´Éµ¿¸é¿ª(È­)(ÊÙÌ´).
  • active immunization
    ´Éµ¿¸é¿ª¹ý, ´Éµ¿¸é¿ªÁ¶Ä¡
  • active incorporative mode
    Àû±ØÀû ÇÔÀÔ ¾ç½Ä
  • active marrow
    Àû°ñ¼ö.
  • active material
    Ȱ¼º¹°Áú(üÀàõÚªòõ).
  • active movement
    ´Éµ¿¿îµ¿(ÒöÔÑê¡ÔÑ)
  • active negativism
    Àû±Ø¼º °ÅÀýÁõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • active immunization
    ´Éµ¿¸é¿ª¹ý, ´Éµ¿¸é¿ªÁ¶Ä¡
  • active immunization
    ´Éµ¿¸é¿ª(È­)(ÊÙÌ´).
  • active incorporative mode
    Àû±ØÀû ÇÔÀÔ ¾ç½Ä
  • active marrow
    Àû°ñ¼ö.
  • active material
    Ȱ¼º¹°Áú(üÀàõÚªòõ).
  • active movement
    ´Éµ¿¿îµ¿(ÒöÔÑê¡ÔÑ)
  • active negativism
    Àû±Ø¼º °ÅÀýÁõ.
  • active oxygen
    Ȱ¼º»ê¼Ò(üÀàõß«áÈ).
  • active shielding
    ´Éµ¿ Â÷Æó
  • active shimming
    ´Éµ¿ º¸Á¤
  • active site
    Ȱ¼ºÀÚ¸®.
  • active spot
    Ȱ¼ºÁ¡(üÀàõïÇ).
  • active tension
    ´Éµ¿Àå·Â(ÒöÔÑíåæ³)
  • active treatment
    Á÷Á¢Ä¡·á, Àû±Ø¿ä¹ý(îÝпèþÛö).
  • active tuberculosis
    Ȱµ¿¼º °áÇÙ(Áõ)(üÀÔÑàõÌ¿ú·ñø).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • biological rhythm
    »ýü(ßæô÷) ¸®µë
  • biological value
    »ý¹°°¡(ßæÚªÊ¤)
  • anion-transport protein
    À½À̿¿î¹Ý(ê¡Úõ) ´Ü¹éÁú(Ó±ÛÜòõ)
  • binding protein transport system
    °áÇÕ ´Ü¹éÁú ¼ö¼Û(Ì¿ùêÓ±ÛÜòõâÃáê) ½Ã½ºÅÛ
  • carbon dioxide transport
    ÀÌ»êȭź¼Ò ¼ö¼Û(ì£ß«ûù÷©áÈâÃáê)
  • cotranslational transport
    ¹ø¿ªµ¿½Ã¼ö¼Û(Ûèæ»ÔÒãÁâÃáê)
  • coupled transport
    "°ø¿ª¼ö¼Û(ÍëæµâÃáê), ¦Áø¼ö¼Û"
  • electron transport chain
    ÀüÀÚ¼ö¼Û(ï³í­âÃáê) »ç½½
  • electron transport particle
    ÀüÀÚ¼ö¼Û ÀÔÀÚ(ï³í­âÃáêØ£í­)
  • electron transport system
    ÀüÀÚ¼ö¼Û(ï³í­âÃáê) ½Ã½ºÅÛ
  • fractional electrical transport
    ºÐº° Àü±â ¼ö¼Û(ÝÂܬï³Ñ¨âÃáê)
  • homocellular transport
    µ¿Áú¼¼Æ÷ ¼ö¼Û(ÔÒòõá¬øàâÃáê)
  • hydrogen transport system
    ¼ö¼Ò ¼ö¼Û(â©áÈâÃáê) ½Ã½ºÅÛ
  • illicit transport
    ¹Ð¼ö¼Û(ÚËâÃáê)
  • intracellular transport
    ¼¼Æ÷³» ¼ö¼Û(á¬øàÒ®âÃáê)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AS acetylstrophanthidin; acidified serum; acoustic schwannoma; acoustic stimulation; active sarcoidosis...
Tm maximum Tubular Transport
CPT carnitine palmityl transferase; carotid pulse tracing; chest physiotherapy; child protection team; c...
CTP California Test of Personality; citrate transport protein; clinical terms project; comprehensive tre...
CVTR charcoal viral transport medium
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MCT Mucociliary transport
NTF2 Nuclear transport factor 2
PST Phosphate Specific Transport
RCT Reverse Cholesterol Transport
"Tm" Transport maximum
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • biological clock
    »ý¹°ÇÐÀû ½Ã°è
  • biological diagnosis
    »ý¹°ÇÐÀû Áø´Ü
  • biological effect
    »ý¹°ÇÐÀû È¿°ú
  • biological engineering
    »ýü °øÇÐ
  • biological factor
    »ý¹°ÇÐÀû ¿äÀÎ
  • biological filtration
    »ý¹°ÇÐÀû °Å¸£±â
  • biological hazard
    »ý¹°ÇÐÀû À§ÇØ
  • biological membrane
    »ýü ¸·
    ¼¼Æ÷ ¶Ç´Â ¼¼Æ÷ ¼Ò±â°üÀÇ °ÑÀ» ½Î°í ÀÖ´Â ¸·. ¹Ì»ý¹°, ½Ä¹°, µ¿¹°ÀÇ ¼¼Æ÷¸·°ú ¿±·Ïü, ¹ÌÅäÄܵ帮¾ÆÀÇ ³», ¿Ü¸·, °ñÁöü, ¼ÒÆ÷ü ¸·, ÇÙ¸· µîÀÌ º¸±âÀÌ´Ù. »ýü¸·ÀÇ ±¸Á¶¿¡ °üÇÑ ¸ðµ¨Àº ¿©·¯ °¡Áö°¡ Á¦½ÃµÇ¾úÀ¸³ª °áÁ¤ÀûÀÎ °ÍÀº ¾ø´Ù. ¿ª»çÀûÀ¸·Î º¼ ¶§ J.F. ´Ù´Ï¿¤ ¸®°¡ Á¦Ã¢Çϰí J.D. ·Î¹öÆ®½¼¿¡ ÀÇÇØ ¼öÁ¤µÈ ´ÜÀ§¸· ¸ðµ¨ÀÌ ÀÖÀ¸¸ç, ±× ÈÄ B. º¥¼Õ µî¿¡ ÀÇÇØ Á¦Ã¢µÈ ¹Ýº¹ ´ÜÀ§ ¸ðµ¨ÀÌ ÀÖ´Ù. ÇöÀç ³Î¸® ÀÎÁ¤¹Þ°í ÀÖ´Â °ÍÀ¸·Î´Â 1972³â S.J. ½Ì°Å µîÀÌ Á¦Ã¢ÇÑ À¯µ¿ ¸ðÀÚÀÌÅ© ¸ðµ¨ÀÌ ÀÖ´Ù. ¸·ÀÇ ÁÖ ¼ººÐÀº ´Ü¹éÁú°ú ÁöÁúÀÌ¸ç µÎ ¼ººÐÀÇ Áß·®ºñ´Â 3:2~3:1·Î ´Ü¹éÁúÀÌ ¸¹´Ù. ÁöÁúÀÇ ÁÖ ¼ººÐÀº ÀÎÁöÁúÀÌ¸ç »ýü¸·ÀÇ ¼ººÐÀ¸·Î ´Ù´ç·ùµµ ¾à°£ Á¸ÀçÇÑ´Ù. ¸·ÀÇ ±¸¼º ¼ººÐÀÎ ÀÎÁöÁú ºÐÀÚ´Â ÀϺκп¡ Ä£¼ö¼º±â¸¦ °¡Áø °¡´À´Ù¶õ ºÐÀڷμ­, ±× ±ä ÃàÀÌ ¸·¸é°ú Á÷°¢À¸·Î ´Ã¾î¼­ ÀÖ°í ¼Ò¼ö¼º ºÎºÐÀÌ ¸¶ÁÖº¸°í ÀÖ¾î 2ºÐÀÚ µÎ²²ÀÇ ¸·À» ¸¸µç´Ù. ´Ü¹éÁúÀº ÁÖ·Î ±¸»ó ´Ü¹éÁúÀ̸ç, ÀÌ ÁöÁú ÀÌÁßÃþ ¼Ó¿¡ ´Ü¹éÁúÀÇ ¼Ò¼ö¼º ºÎºÐÀÌ Àá°Ü ÀÖµíÀÌ Á¸ÀçÇÑ´Ù. ¾î¶² °ÍÀº ¸·ÀÇ ¾ç¸é¿¡ ºÐÀÚÀÇ ÀϺκÐÀ» µå·¯³»°í ÀÖ´Ù. ÀÌ °á°ú ¸·Àº ÁöÁú°ú ´Ü¹éÁúÀÌ ¸ðÀÚÀÌÅ© »óÀ¸·Î Á¸ÀçÇÏ´Â ±¸Á¶°¡ µÈ´Ù. ÁöÁúÀº »ý¸®Àû ¿Âµµ¿¡¼­´Â ¾×üÀ̱⠶§¹®¿¡ ¸· ¼ººÐÀÎ ´Ü¹éÁúÀº ºñ±³Àû ÀÚÀ¯·Ó°Ô ¸·³»¸¦ À̵¿
  • biological microscope
    »ý¹° Çö¹Ì°æ
  • biological oxidation
    »ý¹°ÇÐÀû »êÈ­, »ý¹°ÇÐÀû »êÈ­ÀÛ¿ë
  • biological preparation
    »ý¹°ÇÐ Á¦Á¦
  • biological product
    »ý¹°ÇÐÀû Á¦Á¦
  • biological safety cabinet
    »ý¹°ÇÐÀû ¾ÈÀüÇÔ
  • biological spectrum
    »ý¹° ½ºÆåÆ®·³
  • biological survey
    »ý¹°ÇÐÀû Á¶»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
biological factors Compounds made by living organisms. They have biological or physiological activities.
(12 Dec 1998)
biological half-life <biochemistry, biology> This is the time required for one-half of the total amount of a particular substance in a biological system to be consumed or broken down by biological processes when the rate of removal is approximately exponential.
Toxic chemicals with a long biological half-life (such as some pesticides) will tend to accumulate in the body and are, therefore, more likely to be harmful. A substance with a short biological half-life may still accumulate if a portion of it it becomes tightly bound to bone or other tissues, even if most of it is quickly cleared from the body.
(21 Mar 1998)
biological hazard potential <radiobiology> Measure of the hazard posed by a given quantity of radioactive material in which the variation in biological effects of the various elements are accounted for.
See: integrated biological hazard potential.
(21 Mar 1998)
biological immunotherapy <immunology> Treatment of disease by stimulating the bodys own immune system. This is a type of therapy currently being researched as a treatment for cancer.
(16 Dec 1997)
biological magnification <biology, zoology> The process by which toxins such as pesticides build up in each successive link in the food chain.
For instance, a given population of beetles may have very low levels of a fat-soluble pesticide, but the pesticide will build to much greater levels in the fat of a bird that eats those beetles, and the pesticide will reach greater levels still in a human or panther that eats the beetle-eating birds.
(21 Mar 1998)
biological markers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
(12 Dec 1998)
biological monitoring This is the periodic examination of biological specimens for the purposes of monitoring their exposure to or the effects of potentially toxic chemicals to the environment. This is normally done by analysing the amounts of the toxic substances or their metabolites present in body tissues and fluids. The term is also used to mean assessment of the biological status of populations and communities of organisms at risk, in order to protect them and to gain an early warning of possible hazards to human health.
(09 Oct 1997)
biological oceanography <study> The study of marine plants and animals and the way they interact with the marine environments. Similar to the study of marine biology.
(21 Mar 1998)
biological oxidation Decomposition of organic materials by microorganisms.
(05 Dec 1998)
biological phenomena Biological functions and activities at the organic and molecular levels in humans, animals, microorganisms, and plants. For biochemical and metabolic processes, biochemical phenomena is available.
(12 Dec 1998)
biological products Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay, that depend for their action on the processes affecting immunity. They are used especially in diagnosis and treatment of disease (as vaccines or pollen extracts). Biological products are differentiated from biological factors in that the latter are compounds with biological or physiological activity made by living organisms.
(12 Dec 1998)
biological psychiatry An interdisciplinary science concerned with studies of the biological bases of behaviour - biochemical, genetic, physiological, and neurological - and applying these to the understanding and treatment of mental illness.
(12 Dec 1998)
biological response modifier <pharmacology, oncology> A substance used in adjuvant therapy that takes advantage of the bodys own natural defense mechanisms to inhibit the growth of a tumour.
(16 Dec 1997)
biological response modifiers Substances that stimulate the body's response to infection and disease. The body naturally produces small amounts of these substances. Scientists can produce some of them in the laboratory in large amounts and use them in cancer treatment. Also called BRMs.
(12 Dec 1998)
biological sampling Denotes sampling that can be taken without jeopardy to the whole organism (e.g., for haematological or biochemical study). Because of the complexity of biological samples it is usually supposed that the source of the sample is thoroughly mixed and hence representative; this assumption is often not true e.g., in genetic studies in mosaic patients.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • transport ship
    ¿î¼Û¼±
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á